NIH-funded research R21 grant

Understanding how bacteria survive antibiotic treatment

Official title: Bacterial persistence and proton-motive force

Funded at Texas Engineering Experiment Station · NIH-10734787 · Data updated 2026-11-12

This study is looking at how some bacteria can stick around and cause long-lasting infections even when antibiotics are used, and it’s for anyone interested in understanding why some bacteria are tougher than others when faced with treatment.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionTexas Engineering Experiment Station
NIH-funded
Lab location1 site (College Station, United States)
Project startNovember 4, 2022
Project endOctober 31, 2025
Funding year2024
Award (this year)$151,500
NIH project number5R21AI166636-02
Project IDNIH-10734787 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from chronic infections caused by antibiotic-resistant bacteria.

Less likely to help

Patients with acute infections that respond well to standard antibiotic treatments may not benefit from this research.

What this research studies

This research investigates how certain bacteria can survive antibiotic stress, leading to chronic infections. It focuses on a phenomenon called bacterial persistence, where genetically similar bacteria behave differently under stress. The study aims to quantify variations in the proton-motive force within these bacteria and identify factors that contribute to their survival. By using advanced techniques like optical trapping and fluorescence, researchers hope to uncover the mechanisms behind this survival strategy.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for treating chronic bacterial infections that are resistant to antibiotics.

How similar studies have gone: While the mechanisms of bacterial persistence are not fully understood, similar research has shown promise in identifying survival strategies in bacteria, making this approach both innovative and relevant.

Where this research is happening

  • Texas Engineering Experiment Station
    College Station, United States
    Active

Researchers

  • Principal investigator: Lele, Pushkar Prakash — Texas Engineering Experiment Station
  • Study coordinator: Lele, Pushkar Prakash

Related research

Other NIH-funded projects on the same topics.

  • Robotic dental implants to deliver stem cells

    A new wireless robotic implant approach aims to improve bone healing and implant stability by delivering stem cells directly at the implant site for people needing dental implants.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11591543

  • Digital Twin for Personalized Spine Fracture Prediction in Osteoporosis

    A patient-focused project that uses CT scans and a digital twin model to predict where an osteoporotic spine might fracture during everyday activities.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11577865

  • Nanoparticle therapy to reduce alcohol-related liver scarring and cancer risk

    This project is developing tiny particles that deliver anti-fibrotic medicine to livers damaged by heavy drinking to help reduce scarring and lower the chance of liver cancer.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11456681

  • Smart wrist wearable for continuous cuffless blood pressure and vital signs across diverse skin tones

    A wearable wrist device will continuously monitor blood pressure, heart rate, and breathing in adults of diverse skin tones and body types, using non-invasive sensors and smart algorithms.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11449053

  • Role of the Nucleus in YAP/TAZ Control in Head and Neck Cancer

    Aims to understand how changes in the cell nucleus influence YAP/TAZ pathways that drive head and neck cancer, with the hope of finding biomarkers for treatment response.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11448647

  • Targeted nanoparticle therapy for lung fibrosis

    A researcher team is testing inhaled nanoparticles that deliver medicine directly to the lungs to slow or stop scarring in people with pulmonary fibrosis.

    NIH research Texas Engineering Experiment Station · College Station, United States · NIH-11448075

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.